hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 16:24:49 - browse：853

Three Wegovy injection pens in a row — first opinion coverage from STAT — Adobe

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink.

This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided.

The nine-month study will try three drugs alone and in combinations against placebo. The primary outcome being tested is change in liver scarring, or fibrosis, and one of the secondary outcomes is changes in alcohol consumption. The news of the study was first reported by Bloomberg.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Hospitals struggle to profit from CAR

knowledge

entertainment

WSS

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

After a decade, new Gardasil ad campaign gets it (mostly) right

When a patient nears the end, a feared therapy can comfort

Affordable Connectivity Program vital to health care, experts say

There’s a way to spot data fakery. All journals should be using it

Delta passengers in Vegas fall sick while waiting on flight in triple

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Affirmative action in medical school literally saved lives

5 dead in mass shooting on Caribbean island of St. Vincent: Police

23andMe had bad news about my health. I wish a person had delivered it

Tesla recalling nearly 16,000 of its 2021

BioMarin wins approval for gene therapy to treat hemophilia A

Judge denies Trump's request for new trial in E. Jean Carroll case

Jerome Adams on the need for new antivirals for Covid

When a patient nears the end, a feared therapy can comfort

In age of alternative facts, a scholarly course on calling out crap

Texas Department of Public Safety speaks out on migrant abuse allegations

hotspot

There’s a way to spot data fakery. All journals should be using it

Stanford president faces new allegations over 1999 paper

Tocagen's brain cancer gene therapy trial continues. Investors worry

Texas Department of Public Safety speaks out on migrant abuse allegations

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Stanford president faces new allegations over 1999 paper

hotspot

knowledge

entertainment

knowledge